Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1951 1
1975 1
1976 3
1977 1
1997 2
1998 1
1999 1
2000 1
2001 1
2002 1
2003 1
2004 1
2005 3
2006 4
2007 6
2008 4
2009 8
2010 6
2011 8
2012 12
2013 12
2014 10
2015 20
2016 13
2017 15
2018 16
2019 20
2020 22
2021 17
2022 22
2023 20
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Paz-Mena
Page 1
All Those Worms.
Parekh SG. Parekh SG. Foot Ankle Clin. 2017 Dec;22(4):xv-xvi. doi: 10.1016/j.fcl.2017.09.001. Foot Ankle Clin. 2017. PMID: 29078833 No abstract available.
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
Nastoupil LJ, Hess G, Pavlovsky MA, Danielewicz I, Freeman J, García-Sancho AM, Glazunova V, Grigg A, Hou JZ, Janssens A, Kim SJ, Masliak Z, McKay P, Merli F, Munakata W, Nagai H, Özcan M, Preis M, Wang T, Rowe M, Tamegnon M, Qin R, Henninger T, Curtis M, Caces DB, Thieblemont C, Salles G. Nastoupil LJ, et al. Blood Adv. 2023 Nov 28;7(22):7141-7150. doi: 10.1182/bloodadvances.2023010298. Blood Adv. 2023. PMID: 37722354 Free PMC article. Clinical Trial.
The phase 3 SELENE study evaluated ibrutinib + chemoimmunotherapy (CIT; bendamustine and rituximab [BR]; or rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) for patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone …
The phase 3 SELENE study evaluated ibrutinib + chemoimmunotherapy (CIT; bendamustine and rituximab [BR]; or rituximab, cyclophosphami …
Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ, Qin Y, Zhao ZH, Zhang Y, Yang JH, Zhai DH, Cui F, Luo C, Lu MX, Liu PP, Xu HW, Li K, Sun B, Chen S, Zhou HG, Yang C, Sun T. Liu HJ, et al. Theranostics. 2020 Jul 11;10(20):9083-9099. doi: 10.7150/thno.46467. eCollection 2020. Theranostics. 2020. PMID: 32802180 Free PMC article.
Methods: Selene were synthesized and characterized by TEM, AFM and particle size analysis. ...Results: Selene could effectively inhibit ascites induced by OVCAR-3 and EAC cells. ...
Methods: Selene were synthesized and characterized by TEM, AFM and particle size analysis. ...Results: Selene could effectivel …
Selene: a PyTorch-based deep learning library for sequence data.
Chen KM, Cofer EM, Zhou J, Troyanskaya OG. Chen KM, et al. Nat Methods. 2019 Apr;16(4):315-318. doi: 10.1038/s41592-019-0360-8. Epub 2019 Mar 28. Nat Methods. 2019. PMID: 30923381 Free PMC article.
To enable the application of deep learning in biology, we present Selene (https://selene.flatironinstitute.org/), a PyTorch-based deep learning library for fast and easy development, training, and application of deep learning model architectures for any biological s …
To enable the application of deep learning in biology, we present Selene (https://selene.flatironinstitute.org/), a PyTorch-ba …
Selene-Ethylenelacticamides and N-Aryl-Propanamides as Broad-Spectrum Leishmanicidal Agents.
de Sousa NF, da Silva Souza HD, de Menezes RPB, da Silva Alves F, Acevedo CAH, de Lima Nunes TA, Sessions ZL, Scotti L, Muratov EN, Mendonça-Junior FJB, da Franca Rodrigues KA, de Athayde Filho PF, Scotti MT. de Sousa NF, et al. Pathogens. 2023 Jan 13;12(1):136. doi: 10.3390/pathogens12010136. Pathogens. 2023. PMID: 36678484 Free PMC article.
Hepatocellular Carcinoma: Advances in Systemic Therapy.
Selene II, Ozen M, Patel RA. Selene II, et al. Semin Intervent Radiol. 2024 Mar 14;41(1):56-62. doi: 10.1055/s-0044-1779713. eCollection 2024 Feb. Semin Intervent Radiol. 2024. PMID: 38495258 Review.
HeartInsight: from SELENE HF to implementation in clinical practice.
Zanotto G, Capucci A. Zanotto G, et al. Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C337-C343. doi: 10.1093/eurheartjsupp/suad030. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125280 Free PMC article.
HeartInsight is a new remote monitoring algorithm developed and validated in the SELENE HF study that combines information from a diverse set of sensors integrated into one alert to detect worsening HF with promising accuracy. ...
HeartInsight is a new remote monitoring algorithm developed and validated in the SELENE HF study that combines information from a div …
228 results